Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MOVANTIK 25 MG TABLET

naloxegol oxalate
$14.6308per EA

Strength

25 mg/1

Manufacturer

RedHill Biopharma Ltd

NDC

57841130103

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

NALOXEGOL OXALATE

Approval Type

New Drug (NDA)

FDA Application

NDA204760

On Market Since

10/1/2020

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+4.9%

3Y

+16.0%

5Y

+25.4%

All

+28.6%

Generic Alternatives

2 alternatives • Same active ingredient

MOVANTIK 25 MG TABLET
Brand
57841130101•RedHill Biopharma Ltd
$14.6309
MOVANTIK 25 MG TABLET
Brand
82625880201•Valinor Pharma, LLC
$14.6309

Related Drugs

Same classification

SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
CONTRAVE ER 8-90 MG TABLET
Brand
51267089099•Nalpropion Pharmaceuticals LLC
$4.9810
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2767
per EA
SUBOXONE 4 MG-1 MG SL FILM
Brand
12496120403•Indivior Inc.
$8.5848
per EA
SUBOXONE 8 MG-2 MG SL FILM
Brand
12496120803•Indivior Inc.
$8.5983
per EA
ZUBSOLV 2.9-0.71 MG TABLET SL
Brand
54123092930•Orexo US, Inc.
$10.5396
per EA
ZUBSOLV 5.7-1.4 MG TABLET SL
Brand
54123095730•Orexo US, Inc.
$10.5559
per EA
ZUBSOLV 8.6-2.1 MG TABLET SL
Brand
54123098630•Orexo US, Inc.
$15.8386
per EA
SYMPROIC 0.2 MG TABLET
Brand
59385004130•BioDelivery Sciences International Inc
$16.2809
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy